Abstract
Clopidogrel (Plavix), a platelet aggregation inhibitor, has been shown to be effective in certain patients undergoing percutaneous coronary interventions, but its use in patients with acute myocardial infarction who receive a fibrinolytic strategy instead has been controversial. The aim of the Evidence-Based Medicine (EBM) Section is to bring the readership clinically relevant and practical evidence-based medicine principles and topic reviews. This EBM - Therapy review focuses on a relatively new therapy option for Emergency Department patients with acute myocardial infarction.
| Original language | English (US) |
|---|---|
| Pages (from-to) | 479-483 |
| Number of pages | 5 |
| Journal | Journal of Emergency Medicine |
| Volume | 34 |
| Issue number | 4 |
| DOIs | |
| State | Published - May 2008 |
Keywords
- EBM
- clopidogrel
- drug therapy
- myocardial infarction
- platelet aggregation inhibitors
ASJC Scopus subject areas
- Emergency Medicine
Fingerprint
Dive into the research topics of 'Do Patients with Acute Myocardial Infarction Benefit from Treatment with Clopidogrel?'. Together they form a unique fingerprint.Cite this
- APA
- Standard
- Harvard
- Vancouver
- Author
- BIBTEX
- RIS